NCI to Press FDA For Quicker Drug Approval, Relaxation Of Survival Impact Requirement
In Brief: Tom Hall Names CMMI VP For Clinical Affairs; Rabson, Fauci Names to Institute Of Medicine
Consensus Panel Say Surgery, Radiation Both Effective For Clinically Local Prostate Cancer
Bristol To Support Grants For Studies On Drug Resistance
DCT Board Approves Concept For BRMP Master Agreement
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Johnson and Johnson reaches $5.5B settlement deal over talc lawsuits
- Pour a Scotch, we’re talking clinical trials and prediction markets
- FDA grants Replimune’s RP1 an accelerated approval on third submission after 10:3 vote from advisory committee
Amid political outcry, advisors accept weak data and give sponsor a chance to complete phase III trial - Consumers are increasingly accessing U.S. News rankings of cancer hospitals via AI chatbots
2026 report shows no change in the top-five lineup - The Directors: New directors Herbst and Gius chart a future built on AI, collaboration, and rural access









